Magnolia Market Access at RWE Connect 2026
October 14-15, 2026 | Hampton Inn by Hilton, Boston Seaport District
Magnolia Market Access is heading to RWE Connect 2026 to join conversations shaping the future of real-world evidence, evidence generation, policy, reimbursement, and access strategy.
As biopharma teams face growing expectations around real-world data, payer relevance, evidence quality, and policy-driven decision-making, the ability to connect evidence with access realities has never been more important.
Magnolia Market Access helps manufacturers translate complex market dynamics into actionable strategies that support stronger value communication, smarter launch planning, and more confident access decisions.
Featured Session
RWE and Health Policy: Combining Forces for Access
Amanda Forys, Managing Partner, Magnolia Market Access
Michael Murphy, Director, Real World Evidence & HEOR Strategy, Magnolia Market Access
Wednesday, October 14 | 10:00 AM – 10:30 AM
Meet with Our Team
Magnolia Market Access leaders will be onsite at RWE Connect 2026 and available for one-on-one meetings throughout the conference.
Whether your team is generating real-world evidence, evaluating fit-for-purpose data, preparing for access discussions, or navigating policy and reimbursement considerations, our team can help connect evidence with the access realities that shape coverage and patient access.
Let’s Align Evidence with Access Realities
Magnolia Market Access partners with biopharma teams to build actionable, payer-relevant strategies rooted in real-world evidence, health economics and outcomes research, policy awareness, and market dynamics.
If you are attending RWE Connect 2026 and thinking about how evidence generation, HEOR, health policy, reimbursement, and access strategy come together, let’s talk.
Amanda Forys
Managing Partner
Michael Murphy
Director, RWE & HEOR Strategy
Sean McGonigal
Vice President, Client Services
Request a Meeting
"*" indicates required fields